Correlation of Clinical and Histopathological Features With Anti‐Desmoglein Antibody Profile in Pemphigus Patients
International Journal of Dermatology · 01.07.2026
DOI: 10.1111/ijd.70549 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, online erschienen am 01.07.2026. Verfasst von Dipankar De und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
The desmoglein compensation hypothesis (DCH) proposes that clinical and histopathological features of pemphigus correlate with differential expression of desmoglein 1 (Dsg1) and desmoglein 3 (Dsg3) in skin and mucosa, and corresponding autoantibody profiles. While DCH explains many classical patterns, increasing exceptions have challenged its universality.
Aim
This study aimed to correlate clinical phenotype and histopathological split level with anti‐Dsg1 and anti‐Dsg3 antibody profiles in pemphigus vulgaris (PV) and pemphigus foliaceus (PF), and evaluate consistency with DCH.
Methods
In this bicentric retrospective study, 106 patients with confirmed pemphigus (93 PV, 13 PF) were included. Clinical classification was based on presentation (cutaneous, mucosal, mucocutaneous). Histopathology was reviewed for split level (subcorneal, suprabasal, dual), and serum Dsg1/Dsg3 IgG levels were recorded. Concordance with DCH was assessed.
Results
In PF, splits were subcorneal in 6 (46.2%), suprabasal in 3 (23.1%), and both in 4 (30.7%). Eight (61.5%) had isolated anti‐Dsg1 IgG, consistent with DCH. In PV, 75 (80.6%) had suprabasal splits, 7 (7.5%) dual splits, and 4 (4.3%) subcorneal splits. Among 16 mucosal PV cases, only 6 (37.5%) had isolated anti‐Dsg3 IgG. Highest fidelity to DCH was seen in mucocutaneous PV (56/75; 74.7%) with dual anti‐Dsg1 and Dsg3 positivity. Two patients with cutaneous‐only PV showed dual positivity with suprabasal splits.
Conclusion
While DCH explains many classic presentations, nearly one‐third of patients in our cohort exhibited discordant clinical, serologic, or histologic features. These findings highlight the need for more comprehensive models of pemphigus pathogenesis that incorporate antibody titers, affinity, subclass, and non‐desmoglein targets. image
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
- Department of Dermatology, University of Lübeck, Lübeck, Germany.
ORCID-Profile: Debajyoti Chatterjee, Hitaishi Mehta, Vignesh R Narayan, Rahul Mahajan, Sanjeev Handa
Zitieren
APA
De, D., Chatterjee, D., Mehta, H., Narayan, V. R., Emtenani, S., Kumar, P., Mahajan, R., Handa, S., & Schmidt, E. (2026). Correlation of Clinical and Histopathological Features With Anti‐Desmoglein Antibody Profile in Pemphigus Patients. International Journal of Dermatology. https://doi.org/10.1111/ijd.70549
Vancouver
De D, Chatterjee D, Mehta H, Narayan VR, Emtenani S, Kumar P, et al. Correlation of Clinical and Histopathological Features With Anti‐Desmoglein Antibody Profile in Pemphigus Patients. International Journal of Dermatology. 2026. doi:10.1111/ijd.70549
BibTeX
@article{De2026,
author = {De, Dipankar and Chatterjee, Debajyoti and Mehta, Hitaishi and Narayan, Vignesh R and Emtenani, Shirin and Kumar, Pankaj and Mahajan, Rahul and Handa, Sanjeev and Schmidt, Enno},
title = {Correlation of Clinical and Histopathological Features With Anti‐Desmoglein Antibody Profile in Pemphigus Patients},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70549}
}
EUVIMED